17 completed, 4 not yet recruiting, 2 recruiting, 1 unknown. 11 Not applicable, 4 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 8, Not yet recruiting 2, Recruiting 1 |
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Ichthyosis Bullosa of Siemens: new trials by email Literature Review of Ichthyosis Bullosa of Siemens trials Research Report on Ichthyosis Bullosa of Siemens
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State Acupuncture, Transcutaneous Electrical Acupoint Stimulation, Sham Transcutaneous Electrical Acupoint Stimulation - IBS, Constipation Predominant, Anxiety State | Not applicable | Not yet recruiting | The First Affiliated Hospital of Zhejiang Chinese Medical University | 58 | 2026-10-01 | 2026-10-28 |
| Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome) Chang Ji'an capsule, Chang Ji'an capsule mimic - IBS, Diarrhea Predominant | Phase 3 | Not yet recruiting | Beijing Hospital of Traditional Chinese Medicine | 636 | 2026-05-31 | 2026-05-28 |
| Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study Portable stimulator - IBS, Diarrhea Predominant | Not applicable | Not yet recruiting | First People's Hospital of Foshan | 200 | 2026-03-01 | 2026-02-20 |
| Co-Development and Validation of Colonic Symptom Pictograms for Young People Pictogram comprehension and validation - Constipation - Functional, Abdominal Pain (AP) | Not yet recruiting | University of Auckland, New Zealand | 120 | 2026-01-01 | 2026-01-13 | |
| Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome Saccharomyces Boulardii 250 MG, Placebo 250 mg - IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant) | Phase 3 | Recruiting | Biocodex | 406 | 2025-10-22 | 2025-11-18 |
| The Beneficial Effects on the Intestinal Function of a Food Supplement Based on an Extract of Green Tea and a Pool of Probiotics in Subjects With Irritable Bowel Syndrome With Predominance of Constipation food supplement based on a mixture of green tea extract and a pool of probiotics., Placebo - IBS, Constipation Predominant | Not applicable | Recruiting | Adamas Biotech S.r.l. | 64 | 2025-07-30 | 2025-08-05 |
| Comparison of Rimegepant and Placebo for Pain in IBS Rimegepant 75 MG [Nurtec] - Irritable Bowel Syndrome | Phase 2 | Completed | Mayo Clinic | 39 | 2024-06-06 | 2026-10-15 |
| (FODMAP) Diet on Improving Symptoms of Patients With Irritable Bowel Syndrome Low Fermentable, Oligo-, Di-, Monosaccharides and Polyols (FODMAP) Diet - Irritable Bowel Disease | Not applicable | Completed | Zagazig University | 183 | 2024-06-01 | 2025-12-23 |
| Dieta Mediterranea e Sindrome Dell'Intestino Irritabile in Pazienti Pediatrici dieta mediterranea - Irritable Bowel Syndrome | Unknown | University of Roma La Sapienza | 50 | 2023-02-20 | 2023-02-22 | |
| Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training DiNaMo Study App, Placebo App - Rheumatoid Arthritis, Diabetic Neuropathy | Not applicable | Completed | Click Therapeutics, Inc. | 124 | 2022-10-10 | 2023-04-26 |
| Effect of Curcumin on Gut Microbiota in IBS Curcumin, Placebo - Irritable Bowel Syndrome | Not applicable | Completed | Medical College of Wisconsin | 4 | 2018-08-01 | 2021-02-21 |
| Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation IBS - Irritable Bowel Syndrome | Completed | Abbott | 1000 | 2017-12-25 | 2019-04-25 | |
| International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ) completion of self-reported questionnaires - IBS - Irritable Bowel Syndrome, General Population | Completed | University Paris 7 - Denis Diderot | 300 | 2017-02-10 | 2019-02-18 | |
| The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors No intervention - IBS - Irritable Bowel Syndrome | Completed | Universitas Indonesia | 350 | 2016-11-01 | 2017-06-07 | |
| Effects of Wheat Breads on Symptoms of IBS, a Pilot Study Sourdough wheat bread, Regular yeast baked toast bread, Gluten-free diet - Irritable Bowel Syndrome, Wheat Sensitivity | Not applicable | Completed | Oy Karl Fazer Ab | 26 | 2015-08-01 | 2016-08-05 |
| Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome Traditional Finnish rye bread, Low FODMAP rye bread - Irritable Bowel Syndrome | Not applicable | Completed | Oy Karl Fazer Ab | 87 | 2014-04-01 | 2015-03-31 |
| Neuroimaging and Biomarkers in Chronic Visceral Pain Mindfulness based Stress Reduction Training (MBSR) - Irritable Bowel Syndrome | Not applicable | Completed | University of California, Los Angeles | 119 | 2013-01-01 | 2018-05-14 |
| Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients ROSE-010, Placebo - Irritable Bowel Syndrome Constipation Predominant | Phase 1 / Phase 2 | Completed | Mayo Clinic | 52 | 2010-01-01 | 2013-05-31 |
| Cheno Effect on Transit in Health and IBS-C Sodium chenodeoxycholate (NaCDC), Placebo - Constipation-predominant Irritable Bowel Syndrome | Phase 2 | Completed | Mayo Clinic | 36 | 2009-04-01 | 2012-07-02 |
| Clinical Effectiveness of Exposure Based Cognitive Behavioral Group Therapy for IBS Exposure based face-to-face Cognitive Behavior Group Therapy - Irritable Bowel Syndrome | Not applicable | Completed | Karolinska Institutet | 143 | 2009-01-01 | 2022-04-08 |
Showing 20 of 24. Sign in to see all of them.
Irritable Bowel Syndrome (17) · Anxiety Disorders (2) · Constipation (2) · Abdominal Pain (1) · Arthritis, Rheumatoid (1) · Diabetic Neuropathies (1) · Fibromyalgia (1) · Flatulence (1) · Gastrointestinal Diseases (1) · Nausea (1) · Pain (1)
Congenital Abnormalities (24) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (24) · Genetic Diseases, Inborn (24) · Ichthyosis (24) · Infant, Newborn, Diseases (24) · Keratosis (24) · Skin Abnormalities (24) · Skin Diseases (24) · Skin Diseases, Genetic (24) · Skin and Connective Tissue Diseases (24) · Colonic Diseases (17) · Colonic Diseases, Functional (17) · Digestive System Diseases (17) · Intestinal Diseases (17) · Gastrointestinal Diseases (16)
Acupuncture Therapy (1) · Chenodeoxycholic Acid (1) · Curcumin (1) · Diet (1) · Diet, Gluten-Free (1) · Diet, Mediterranean (1) · Glucagon-Like Peptide 1 (1) · Mindfulness (1) · Monosaccharides (1) · glucagon-like peptide (7-37), valyl(10)- (1) · polyol (1) · rimegepant sulfate (1) · tebufenozide (1)
Mayo Clinic (3) · Oy Karl Fazer Ab (2) · University of North Carolina, Chapel Hill (2) · AGI Therapeutics, Inc. (1) · Abbott (1) · Adamas Biotech S.r.l. (1) · Beijing Hospital of Traditional Chinese Medicine (1) · Biocodex (1) · Click Therapeutics, Inc. (1) · Dynogen Pharmaceuticals (1) · First People's Hospital of Foshan (1) · Karolinska Institutet (1) · Medical College of Wisconsin (1) · The First Affiliated Hospital of Zhejiang Chinese Medical University (1) · Universitas Indonesia (1)
United States (9) · China (2) · Finland (2) · Spain (2) · Canada (1) · Egypt (1) · France (1) · Indonesia (1) · Italy (1) · Portugal (1) · Russia (1) · United Kingdom (1)
Benoit Coffin, MD, PhD (1) · Douglas Drossman, MD (1) · Fernando Azpiroz, MD, PhD (1) · Giovanni Di Nardo (1) · Hanaa A Nofal, MD (1) · Jiande Chen, Prof. (1) · Kirsten Tillisch, MD (1) · Manu Sood, MD (1) · Martin Duracinsky, MD, PhD (1) · Michael Camilleri (1) · Michael Camilleri, MD (1) · Michael L. Camilleri, M.D. (1) · Oana Bernard, DR (1) · Olivier Chassany, MD, PhD (1) · Perjohan Lindfors, PhD, MD (1)
PMID 19638214, PMID 20691689, PMID 22517769, PMID 27144627, PMID 31327218, PMID 32153925, PMID 35088760, PMID 35260030, PMID 35973183, PMID 36052114, PMID 41637861
UL1RR024150 (2), 1RC1DK086182 (1), R01AT007137 (1), R01DK054681 (1), R01DK079866 (1), R21AT003619 (1), UL1TR001436 (1)